Westerkirk Capital Inc. Zoetis Inc. Transaction History
Westerkirk Capital Inc.
- $875 Billion
- Q3 2025
A detailed history of Westerkirk Capital Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Westerkirk Capital Inc. holds 42,900 shares of ZTS stock, worth $5.1 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
42,900
Previous 33,700
27.3%
Holding current value
$5.1 Million
Previous $5.26 Billion
19.44%
% of portfolio
0.72%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding ZTS
# of Institutions
2,088Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...